This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
| Code | Display |
| 13361-1 | Semen analysis panel |
| 15129-0 | Deprecated Fibrin D-dimer EIA |
| 24313-9 | Hepatitis 1996 panel - Serum |
| 24314-7 | TORCH 1996 panel - Serum |
| 24315-4 | Cytomegalovirus IgG and IgM panel - Serum |
| 24316-2 | Epstein Barr virus capsid IgG and IgM panel - Serum |
| 24317-0 | Hemogram and platelets WO differential panel - Blood |
| 24318-8 | Manual Differential panel - Blood |
| 24319-6 | Cardiolipin IgG and IgM panel - Serum |
| 24320-4 | Basic metabolic 1998 panel - Serum or Plasma |
| 24321-2 | Basic metabolic 2000 panel - Serum or Plasma |
| 24322-0 | Comprehensive metabolic 1998 panel - Serum or Plasma |
| 24323-8 | Comprehensive metabolic 2000 panel - Serum or Plasma |
| 24324-6 | Hepatic function 1996 panel - Serum or Plasma |
| 24325-3 | Hepatic function 2000 panel - Serum or Plasma |
| 24326-1 | Electrolytes 1998 panel - Serum or Plasma |
| 24327-9 | Electrolytes 3 panel - Body fluid |
| 24328-7 | Electrolytes 3 panel - Stool |
| 24329-5 | Electrolytes 3 panel - Urine |
| 24331-1 | Lipid 1996 panel - Serum or Plasma |
| 24332-9 | Alkaline phosphatase isoenz panel - Serum or Plasma |
| 24333-7 | Amylase isoenzyme 3 panel - Serum or Plasma |
| 24334-5 | Amylase isoenzyme 7 panel - Serum |
| 24335-2 | Creatine kinase panel - Serum or Plasma |
| 24336-0 | Gas panel - Arterial blood |
| 24337-8 | Gas panel - Capillary blood |
| 24338-6 | Gas panel - Blood |
| 24339-4 | Gas panel - Venous blood |
| 24340-2 | Gas panel - Body fluid |
| 24341-0 | Gas and Carbon monoxide panel - Arterial blood |
| 24342-8 | Gas and Carbon monoxide panel - Capillary blood |
| 24343-6 | Gas and Carbon monoxide panel - Blood |
| 24344-4 | Gas and Carbon monoxide panel - Venous blood |
| 24345-1 | Deprecated Gas & CO panel |
| 24346-9 | Parathyrin.intact and Calcium panel - Serum or Plasma |
| 24347-7 | Parathyrin.mid molecule and Calcium panel - Serum or Plasma |
| 24348-5 | Free T4 and TSH panel - Serum or Plasma |
| 24349-3 | Drugs of abuse 5 panel - Urine |
| 24350-1 | Volatiles panel - Urine |
| 24351-9 | Protein electrophoresis panel - Serum or Plasma |
| 24352-7 | Protein electrophoresis panel - Cerebral spinal fluid |
| 24353-5 | Glucose tolerance 2 hours gestational panel - Urine and Serum or Plasma |
| 24356-8 | Urinalysis complete panel - Urine |
| 24357-6 | Urinalysis macro (dipstick) panel - Urine |
| 24358-4 | Hemogram without Platelets panel - Blood |
| 24359-2 | Hemogram without Platelets and with Manual Differential panel - Blood |
| 24360-0 | Hemoglobin and Hematocrit panel - Blood |
| 24361-8 | Deprecated Hemogram, platelets & Differential panel in Blood |
| 24362-6 | Renal function 2000 panel - Serum or Plasma |
| 24363-4 | Acute hepatitis 2000 panel - Serum Qualitative |
| 24364-2 | Obstetric 1996 panel - Serum and Blood |
| 24365-9 | Urinalysis microscopic panel - Urine sediment |
| 29576-6 | Bacterial susceptibility panel |
| 29577-4 | Fungal susceptibility panel |
| 29578-2 | Viral susceptibility panel |
| 29579-0 | Mycobacterial susceptibility panel |
| 29580-8 | Differential panel - Body fluid |
| 29581-6 | Differential panel - Peritoneal fluid |
| 29582-4 | Differential panel - Synovial fluid |
| 29583-2 | Differential panel - Pleural fluid |
| 29584-0 | Differential panel - Cerebral spinal fluid |
| 29585-7 | Immunoelectrophoresis panel - Urine |
| 29586-5 | Immunoelectrophoresis panel - Serum |
| 29587-3 | Toxicology panel - Blood |
| 29588-1 | Heavy metals panel - Blood |
| 29589-9 | Heavy metals panel - Urine |
| 34527-2 | Deprecated Hemogram, Platelets, Differential & Reticulocyte panel in Blood |
| 34528-0 | PT panel - Platelet poor plasma by Coagulation assay |
| 34529-8 | PT and aPTT panel - Platelet poor plasma by Coagulation assay |
| 34530-6 | ABO and Rh group panel - Blood |
| 34531-4 | Blood type and Crossmatch panel - Blood |
| 34532-2 | Blood type and Indirect antibody screen panel - Blood |
| 34534-8 | EKG 12 channel panel |
| 34535-5 | Microalbumin/Creatinine panel in random Urine |
| 34536-3 | Fluid intake and output panel 24 hour |
| 34537-1 | Fluid intake and output panel 8 hour |
| 34539-7 | Protein electrophoresis panel - Urine |
| 34540-5 | Phenytoin free and total panel [Mass/volume] - Serum or Plasma |
| 34541-3 | ACTH stimulation test using IM corticosteroids in Serum or Plasma |
| 34542-1 | ACTH stimulation test using IV corticosteroids in Serum or Plasma |
| 34543-9 | Bilirubin direct and total panel [Mass/volume] - Serum or Plasma |
| 34544-7 | Complement C3 and C4 panel [Mass/volume] - Serum or Plasma |
| 34545-4 | Carbamazepine free and total panel [Mass/volume] - Serum or Plasma |
| 34546-2 | Protein and Glucose panel [Mass/volume] - Cerebral spinal fluid |
| 34547-0 | Complement profile panel [Mass/volume] - Serum or Plasma |
| 34548-8 | Sodium and Potassium panel [Moles/volume] - Serum or Plasma |
| 34549-6 | Follitropin and Lutropin panel [Units/volume] - Serum or Plasma |
| 34550-4 | Immunoglobulin panel [Mass/volume] - Serum |
| 34551-2 | Catecholamines 3 panel [Mass/volume] - Plasma |
| 34552-0 | 2D echocardiogram panel |
| 34553-8 | Orthostatic blood pressure panel |
| 34554-6 | Electrolytes 1998 and Venous pH panel - Serum or Plasma + Blood venous |
| 34555-3 | Creatinine 24H renal clearance panel |
| 34556-1 | Cell count panel - Body fluid |
| 34557-9 | Cell count and Differential panel - Body fluid |
| 34558-7 | Cell count panel - Peritoneal fluid |
| 34559-5 | Cell count panel - Synovial fluid |
| 34560-3 | Cell count and Differential panel - Synovial fluid |
| 34561-1 | Cell count panel - Pleural fluid |
| 34562-9 | Cell count and Differential panel - Pleural fluid |
| 34563-7 | Cell count panel - Cerebral spinal fluid |
| 34564-5 | Cell count and Differential panel - Cerebral spinal fluid |
| 34565-2 | Vital signs, weight and height panel |
| 34566-0 | Vital signs with method details panel |
| 34567-8 | Cell count and Differential panel - Peritoneal fluid |
| 34665-0 | TORCH panel - Cerebral spinal fluid |
| 34667-6 | Heavy metals panel - Hair |
| 34672-6 | Immunoelectrophoresis panel - 24 hour Urine |
| 34940-7 | Babesia microti IgG and IgM panel - Serum |
| 34941-5 | Bordetella pertussis IgG and IgM panel - Serum |
| 34942-3 | Borrelia burgdorferi IgG and IgM panel - Serum |
| 34943-1 | Borrelia burgdorferi IgG and IgM panel - Cerebral spinal fluid |
| 34944-9 | Cytomegalovirus IgG and IgM panel - Cerebral spinal fluid |
| 34945-6 | Herpes virus 6 IgG and IgM panel - Serum |
| 34946-4 | Herpes virus 6 IgG and IgM panel - Cerebral spinal fluid |
| 34947-2 | Herpes virus 7 IgG and IgM panel - Serum |
| 34948-0 | Measles virus IgG and IgM panel - Serum |
| 34949-8 | Measles virus IgG and IgM panel - Cerebral spinal fluid |
| 34950-6 | Parvovirus B19 IgG and IgM panel - Serum |
| 34951-4 | Phosphatidylserine IgG and IgM panel - Serum |
| 34952-2 | Rubella virus IgG and IgM panel - Serum |
| 34953-0 | Rubella virus IgG and IgM panel - Cerebral spinal fluid |
| 34954-8 | Treponema pallidum IgG and IgM panel - Serum |
| 34955-5 | Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid |
| 34994-4 | Smear morphology panel - Blood |
| 35083-5 | Amino acids panel [Moles/volume] - Serum or Plasma |
| 35084-3 | Fetal lung maturity in Amniotic fluid |
| 35085-0 | Deprecated Newborn screening panel American College of Medical Genetics (ACMG) |
| 35086-8 | Second trimester triple maternal screen panel - Serum or Plasma |
| 35087-6 | Amino acids panel - Urine |
| 35088-4 | Glasgow coma scale |
| 35089-2 | History and physical panel |
| 35090-0 | Patient history |
| 35091-8 | Patient physical |
| 35092-6 | Urology testicular ultrasound |
| 35093-4 | Urology urinary tract ultrasound |
| 35094-2 | Blood pressure panel |
| 35095-9 | Body temperature panel |
| 35096-7 | OB ultrasound panel |
| 35499-3 | Pesticide and Insecticide panel [Mass/volume] - Serum or Plasma |
| 35500-8 | Pesticide and Insecticide panel [Mass/volume] - Urine |
| 35501-6 | Pesticide and Insecticide panel [Mass/volume] - Urine and Serum or Plasma |
| 35502-4 | Mitochondrial myopathy enzyme panel [Enzymatic activity/mass] - Tissue |
| 35507-3 | Amino acids panel [Moles/volume] - Cerebral spinal fluid |
| 35508-1 | Amino acids panel [Moles/volume] - Amniotic fluid |
| 35509-9 | Amino acids panel [Moles/time] - 24 hour Urine |
| 35558-6 | Cholinesterase panel [Enzymatic activity/volume] - Blood |
| 35563-6 | Rickettsia rickettsii IgG and IgM panel - Serum |
| 35575-0 | Pigeon antibody panel - Serum |
| 35576-8 | Hydrocarbon and Oxygenated Volatiles panel - Serum or Plasma |
| 35577-6 | Hypersensitivity pneumonitis panel - Serum |
| 35650-1 | Lymphocytic choriomeningitis virus IgG and IgM panel - Cerebral spinal fluid |
| 35666-7 | Lymphocytic choriomeningitis virus IgG and IgM panel - Serum |
| 35679-0 | Varicella zoster virus IgG and IgM panel - Cerebral spinal fluid |
| 35680-8 | Hepatitis E virus IgG and IgM panel - Serum |
| 35681-6 | Tissue transglutaminase Ab panel - Serum |
| 35682-4 | Trypanosoma cruzi IgG and IgM panel - Serum |
| 35683-2 | Burkholderia pseudomallei IgG and IgM panel - Serum |
| 35684-0 | Colorado tick fever virus IgG and IgM panel - Serum |
| 35739-2 | Brucella sp IgG and IgM panel - Serum |
| 35740-0 | Rickettsia sp IgG and IgM panel - Serum |
| 35743-4 | Eastern equine encephalitis virus IgG and IgM panel - Unspecified specimen |
| 35752-5 | Escherichia coli O157:H7 IgG and IgM panel - Serum |
| 35866-3 | Organic acids panel - Serum or Plasma |
| 38212-7 | Pain assessment panel |
| 38213-5 | FLACC pain assessment panel |
| 38228-3 | Braden scale skin assessment panel |
| 38269-7 | Study report Skeletal system DXA |
| 38351-3 | Herpes virus 6 DNA panel - Unspecified specimen by Probe and target amplification method |
| 39135-9 | Wound assessment panel |
| 39136-7 | Deprecated Skin assessment panel |
| 39137-5 | Oral assessment panel |
| 41359-1 | Active range of motion panel Quantitative |
| 41360-9 | Passive range of motion panel Quantitative |
| 41478-9 | Bartonella henselae IgG and IgM panel - Serum |
| 41482-1 | Chlamydia sp IgG and IgM panel [Titer] - Serum |
| 41484-7 | Coxsackievirus A Ab panel [Titer] - Serum by Complement fixation |
| 41485-4 | Coxsackievirus B Ab panel [Titer] - Serum by Complement fixation |
| 41486-2 | Coxsackievirus B Ab panel [Titer] - Serum by Neutralization test |
| 41493-8 | Febrile agglutinin Ab panel [Titer] - Serum |
| 41505-9 | Parainfluenza virus Ag panel - Unspecified specimen by Immunofluorescence |
| 41506-7 | Polio virus Ab panel [Titer] - Serum by Neutralization test |
| 41839-2 | Burkholderia pseudomallei IgG and IgM panel - Serum by Immunofluorescence |
| 41840-0 | Coxiella burnetii phase 1 and 2 IgG panel [Titer] - Serum |
| 41841-8 | Coxiella burnetii phase 1 and 2 IgM panel [Titer] - Serum |
| 41842-6 | Herpes virus 7 IgG and IgM panel [Titer] - Serum by Immunofluorescence |
| 41843-4 | Lymphocytic choriomeningitis virus IgG and IgM panel [Titer] - Cerebral spinal fluid by Immunofluorescence |
| 41875-6 | Bordetella pertussis and Bordetella parapertussis DNA panel - Unspecified specimen by Probe and target amplification method |
| 41876-4 | Rickettsia typhi and Rickettsia spotted fever group IgG and IgM panel - Serum |
| 41877-2 | Bordetella pertussis IgA and IgG and IgM panel [Units/volume] - Serum by Immunoassay |
| 41878-0 | Dengue virus IgG and IgM panel [Units/volume] - Serum by Immunoassay |
| 42191-7 | Hepatitis A and B and C 7a panel - Serum |
| 42218-8 | Sulfatide IgG and IgM panel - Serum |
| 42342-6 | Rickettsia (Proteus) Ab panel - Serum |
| 42359-0 | Streptococcus pneumoniae 14b IgG panel [Mass/volume] - Serum |
| 42360-8 | Streptococcus pneumoniae 14a IgG panel [Mass/volume] - Serum |
| 42361-6 | Streptococcus pneumoniae 12 IgG panel [Mass/volume] - Serum |
| 42362-4 | Streptococcus pneumoniae 7b IgG panel [Mass/volume] - Serum |
| 42363-2 | Streptococcus pneumoniae 7a IgG panel [Mass/volume] - Serum |
| 42364-0 | Streptococcus pneumoniae 6 IgG panel [Mass/volume] - Serum |
| 42365-7 | Streptococcus pneumoniae 4 IgG panel [Mass/volume] - Serum |
| 42366-5 | Streptococcus pneumoniae 23 IgG panel [Mass/volume] - Serum |
| 42760-9 | Inflammatory bowel disease Ab panel - Serum |
| 42770-8 | Human papilloma virus high and Low risk DNA panel - Cervix |
| 42929-0 | Lactate dehydrogenase panel - Serum or Plasma |
| 43098-3 | Yersinia sp Ab panel - Serum |
| 43099-1 | Vanillylmandelate panel - 24 hour Urine |
| 43100-7 | Sjogrens syndrome-A and B extractable nuclear Ab panel - Serum |
| 43101-5 | Phosphatidylserine IgA and IgG and IgM panel - Serum |
| 43104-9 | Paraneoplastic Ab panel - Serum |
| 43105-6 | Acetaldehyde and Paraldehyde panel [Mass/volume] - Serum or Plasma |
| 43106-4 | Amitriptyline and Nortriptyline panel [Mass/volume] - Serum or Plasma |
| 43107-2 | Mycoplasma sp and Ureaplasma sp panel - Unspecified specimen by Organism specific culture |
| 43108-0 | Metanephrine and Normetanephrine panel [Mass/volume] - Serum or Plasma |
| 43109-8 | Leishmania sp IgG and IgM panel - Serum |
| 43110-6 | Immunoglobulin light chains panel - 24 hour Urine |
| 43112-2 | Herpes simplex virus Ab panel - Serum |
| 43113-0 | Hemoglobin electrophoresis panel in Blood |
| 43116-3 | Porphyrin fractions panel - 24 hour Urine |
| 43117-1 | Fluoxetine and Norfluoxetine panel [Mass/volume] - Serum or Plasma |
| 43118-9 | Fat panel - Stool |
| 43119-7 | Extractable nuclear Ab panel - Serum |
| 43120-5 | Echovirus Ab panel - Serum |
| 43122-1 | Doxepin and Nordoxepin panel [Mass/volume] - Serum or Plasma |
| 43123-9 | Imipramine and Desipramine panel [Mass/volume] - Serum or Plasma |
| 43124-7 | Cystine panel - Urine |
| 43125-4 | Nicotine and Metabolites panel [Mass/volume] - Urine |
| 43126-2 | Cortisol.free panel - 24 hour Urine |
| 43127-0 | Clomipramine and Norclomipramine panel [Mass/volume] - Serum or Plasma |
| 43128-8 | Chloride panel - 24 hour Urine |
| 43129-6 | Brucella abortus IgG and IgM panel - Serum |
| 43130-4 | Bile acid fractions panel [Moles/volume] - Serum |
| 43131-2 | Bacterial Ag panel - Cerebral spinal fluid |
| 43133-8 | Allopurinol and Oxipurinol panel [Mass/volume] - Serum or Plasma |
| 43134-6 | Calcidiol and Calciferol and Calcitriol panel [Mass/volume] - Serum or Plasma |
| 43135-3 | 17-Ketosteroids and 17-Ketogenic steroids panel - 24 hour Urine |
| 43141-1 | Synthetic glucocorticoid panel [Mass/volume] - Serum or Plasma |
| 43142-9 | Height measurement device panel |
| 43143-7 | Weighing device panel |
| 43144-5 | Pedometer device panel |
| 43145-2 | Peak flow meter device panel |
| 43146-0 | Oxygen saturation device panel |
| 43147-8 | Metabolism measurement device panel |
| 43148-6 | Insulin delivery device panel |
| 43149-4 | Heart rate device panel |
| 43150-2 | Hemoglobin A1c measurement device panel |
| 43151-0 | Glucose meter device panel |
| 43152-8 | Blood pressure device panel |
| 43153-6 | Blood coagulation device panel |
| 43309-4 | Desmoglein 1 and Desmoglein 3 Ab panel [Units/volume] - Serum |
| 43433-2 | Acylcarnitine panel - Serum or Plasma |
| 43434-0 | Bacterial Ag panel - Serum |
| 43435-7 | Bartonella henselae and Bartonella quintana IgM panel - Cerebral spinal fluid |
| 43436-5 | Bartonella henselae and Bartonella quintana IgG panel - Cerebral spinal fluid |
| 43437-3 | Bartonella henselae and Bartonella quintana IgG and IgM panel - Cerebral spinal fluid |
| 43438-1 | Bartonella henselae and Bartonella quintana IgG and IgM panel - Serum |
| 43439-9 | Bartonella henselae and Bartonella quintana IgG panel [Titer] - Serum |
| 43440-7 | Bartonella henselae and Bartonella quintana IgM panel [Titer] - Serum |
| 43443-1 | Bacterial Ag panel - Urine |
| 43674-1 | Fatty Acid Panel Comprehensive C8-C26 - Serum or Plasma |
| 43675-8 | Fatty Acid Panel Mitochondrial C8-C18 - Serum or Plasma |
| 43676-6 | Fatty Acid Panel Essential C12-C22 - Serum or Plasma |
| 43677-4 | Fatty Acid Panel Peroxisomal C22-C26 - Serum or Plasma |
| 44249-1 | PHQ-9 quick depression assessment panel [Reported.PHQ] |
| 44616-1 | Pulse oximetry panel |
| 4463-6 | Spermatozoa motility and count panel |
| 44789-6 | Amylase and Creatinine clearance panel - Urine and Serum or Plasma |
| 44791-2 | Menorrhagia coagulation panel - Platelet poor plasma |
| 44792-0 | Immunoglobulin light chains panel - Urine |
| 44793-8 | Immunoglobulin light chains panel [Mass/volume] - Serum |
| 44906-6 | Homovanillate panel - 24 hour Urine |
| 44907-4 | 5-Hydroxyindoleacetate panel - 24 hour Urine |
| 45023-9 | HLA typing for celiac disease panel - Blood |
| 45024-7 | HLA typing for narcolepsy panel - Blood |
| 45027-0 | HLA-A2 panel - Blood |
| 45033-8 | Cardiovascular assessment panel |
| 45057-7 | Cardiolipin IgA and IgG and IgM panel - Serum |
| 45058-5 | Cyclosporine Monoclonal and Polyclonal panel [Mass/volume] - Blood |
| 45059-3 | Ehrlichia chaffeensis IgG and IgM panel [Titer] - unspecified time Serum by Immunofluorescence |
| 45060-1 | Protein and Glucose panel - Urine by Test strip |
| 45061-9 | Spermatozoa IgA and IgG and IgM panel - Serum |
| 45063-5 | Varicella zoster virus IgG and IgM panel - Serum |
| 45064-3 | Deprecated Basic metabolic panel & Glomerular filtration rate.predicted |
| 45065-0 | Deprecated Comprehensive metabolic panel & Glomerular filtration rate.predicted |
| 45066-8 | Creatinine and Glomerular filtration rate.predicted panel |
| 45174-0 | Herpes gestationis Ab panel - Serum |
| 45268-0 | Immunodeficiency panel - Blood by Flow cytometry (FC) |
| 45269-8 | Chronic leukemia panel - Unspecified specimen by Flow cytometry (FC) |
| 45270-6 | Acute leukemia panel - Unspecified specimen by Flow cytometry (FC) |
| 45350-6 | Tick identification panel |
| 45962-8 | Minimum data set for nursing home resident assessment and care screen |
| 45963-6 | MDS basic assessment tracking form - version 2.0 |
| 45964-4 | Identification information section |
| 45965-1 | Name Set |
| 45966-9 | Social security and medicare numbers Set |
| 45967-7 | Facility provider numbers Set |
| 45968-5 | Reasons for assessment (basic) Set |
| 45969-3 | MDS background information at admission form - version 2.0 |
| 45970-1 | Demographic information section |
| 45971-9 | Residential history 5 years prior to entry Set |
| 45972-7 | Language Set |
| 45973-5 | Conditions related to mental retardation and developmental disabilities status Set |
| 45974-3 | Mental retardation and developmental disabilities with organic condition Set |
| 45975-0 | Customary routine section |
| 45976-8 | Customary routine in year prior to date of entry Set |
| 45977-6 | Cycle of daily events Set |
| 45978-4 | Eating patterns Set |
| 45979-2 | ADL patterns Set |
| 45980-0 | Involvement patterns Set |
| 45981-8 | MDS full assessment form - version 2.0 |
| 45982-6 | Identification and background information section |
| 45983-4 | Assessment reference date Set |
| 45984-2 | Current payment sources for nursing home stay Set |
| 45985-9 | Responsibility/legal guardian Set |
| 45986-7 | Advance directives Set |
| 45987-5 | Cognitive patterns section |
| 45988-3 | Memory Set |
| 45989-1 | Memory recall/ability Set |
| 45990-9 | Indicators of delirium - periodic disorded thinking or awareness Set |
| 45991-7 | Communication and hearing patterns section |
| 45992-5 | Communication devices and techniques Set |
| 45993-3 | Modes of expression Set |
| 45994-1 | Vision patterns section |
| 45995-8 | Visual limitations and dificulties Set |
| 45996-6 | Mood and behavior patterns section |
| 45997-4 | Indicators of depression, anxiety, sad mood Set |
| 45998-2 | Verbal expressions of distress Set |
| 45999-0 | Sleep-cycle issues Set |
| 46000-6 | Sad, apethetic, anxious appearance Set |
| 46001-4 | Behavioral symptoms Set |
| 46002-2 | Psychosocial well-being section |
| 46003-0 | Sense of initiative/involvement Set |
| 46004-8 | Unsettled releationships Set |
| 46005-5 | Past roles Set |
| 46006-3 | Physical functioning and stuctural problems section Set |
| 46007-1 | ADL self performance or support Set |
| 46008-9 | Bathing |
| 46009-7 | Test for balance Set |
| 46010-5 | Functional limitation in range of motion Set |
| 46011-3 | Modes of locomotion Set |
| 46012-1 | Modes of transfer Set |
| 46013-9 | ADL functional rehabilitation potential Set |
| 46014-7 | Continence in last 14 days section Set |
| 46015-4 | Continence self-control categories Set |
| 46016-2 | Bowel elimination pattern Set |
| 46017-0 | Continence appliances and programs Set |
| 46018-8 | Disease or condition diagnoses section |
| 46019-6 | Diseases or conditions Set |
| 46020-4 | Endocrine, metabolic or nutritional diseases or conditions Set |
| 46021-2 | Heart or circulation diseases or conditions Set |
| 46022-0 | Musculoskeletal diseases or conditions Set |
| 46023-8 | Neurological diseases or conditions Set |
| 46024-6 | Psychiatric or mood diseases or conditions Set |
| 46025-3 | Pulmonary diseases or conditions Set |
| 46026-1 | Sensory diseases or conditions Set |
| 46027-9 | Other diseases or conditions Set |
| 46028-7 | Infections Set |
| 46029-5 | Other current or more detailed diagnoses and ICD9 codes Set |
| 46030-3 | Health conditions section |
| 46031-1 | Indicators of fluid status Set |
| 46032-9 | Other indicators Set |
| 46033-7 | Pain symptoms Set |
| 46034-5 | Pain site Set |
| 46035-2 | Accidents Set |
| 46036-0 | Stability of conditions Set |
| 46037-8 | Oral and nutritional status section |
| 46038-6 | Oral problems Set |
| 46039-4 | Height and weight Set |
| 46040-2 | Weight change Set |
| 46041-0 | Nutritional problems Set |
| 46042-8 | Nutritional approaches Set |
| 46043-6 | Parenteral or enteral intake Set |
| 46044-4 | Oral or dental status section |
| 46045-1 | Oral status and disease prevention Set |
| 46046-9 | Skin condition section |
| 46047-7 | Ulcers Set |
| 46048-5 | Type of ulcer Set |
| 46049-3 | Other skin problems or lesions present Set |
| 46050-1 | Skin treatments Set |
| 46051-9 | Foot problems and care Set |
| 46052-7 | Activity pursuit patterns section |
| 46053-5 | Time awake Set |
| 46054-3 | Preferred activity settings Set |
| 46055-0 | General activity preferences Set |
| 46056-8 | Prefers change in daily routine Set |
| 46057-6 | Medications section |
| 46058-4 | Days received the following medication Set |
| 46059-2 | Special treatments and procedures section |
| 46060-0 | Special treatments, procedures and programs Set |
| 46061-8 | Special care Set |
| 46062-6 | Treatments Set |
| 46063-4 | Programs Set |
| 46064-2 | Therapies Set |
| 46065-9 | Intervention programs for mood, behavior and cognitive loss Set |
| 46066-7 | Nursing rehabilitation and restorative care Set |
| 46067-5 | Devices and restraints Set |
| 46068-3 | Discharge potential and overall status section |
| 46069-1 | Discharge potential Set |
| 46070-9 | Assessment information section |
| 46071-7 | Participation in assessment Set |
| 46072-5 | Therapy supplement for Medicare PPS section |
| 46073-3 | Special treatments and procedures Set |
| 46074-1 | Recreational therapy Set |
| 46075-8 | Walking when most self sufficient Set |
| 46076-6 | Minimum Data Set (MDS) supplemental items section - version 2.0 |
| 46077-4 | Influenza vaccine Set |
| 46078-2 | Pneumococcal vaccine Set |
| 46079-0 | Resident assessment protocol summary section |
| 46101-2 | Ordered therapies Set |
| 46102-0 | MDS quarterly assessment form - version 2.0 |
| 46103-8 | MDS quarterly assessment form - version 2.0 - optional version for RUG-III |
| 46104-6 | MDS quarterly assessment form - version 2.0 - optional version for RUG-III 1997 update |
| 46105-3 | Problem conditions Set |
| 46107-9 | Loss of interest Set |
| 46437-0 | Rheumatoid Factor and Cyclic Citrullinated Peptide IgG panel [Units/volume] - Serum |
| 46611-0 | Mental residual functional capacity (RFC) assessment form |
| 46612-8 | Summary conclusions Set |
| 46637-5 | Residual physical functional capacity (RFC) assessment form [RFC] |
| 46959-3 | Synthetic glucocorticoid panel [Mass/volume] - Urine |
| 46993-2 | HLA Ab panel - Serum |
| 46999-9 | Bacterial vaginosis and vaginitis rRNA panel - Vaginal fluid by DNA probe |
| 47245-6 | HIV treatment form Document |
| 47246-4 | HIV Antiretroviral therapy Demographic information section |
| 47248-0 | HIV Antiretroviral therapy Antiretroviral therapy status section |
| 47249-8 | HIV Antiretroviral therapy HIV care and family status section |
| 47286-0 | Differential panel - Bone marrow |
| 47287-8 | Deprecated Hemogram without Platelets panel in Cord blood |
| 47288-6 | CBC WO Differential panel - Cord blood |
| 47289-4 | IgG and IgG subclass panel [Mass/volume] - Serum |
| 47290-2 | IgG subclass panel [Mass/volume] - Serum |
| 47531-9 | Wet mount panel - Vaginal fluid |
| 48073-1 | Thyroxine binding globulin panel [Mass/volume] - Serum or Plasma by Electrophoresis |
| 48593-8 | von Willebrand panel - Platelet poor plasma |
| 48596-1 | Activated protein C resistance panel - Platelet poor plasma |
| 48615-9 | Insulin.free and Insulin.total panel [Units/volume] - Serum or Plasma |
| 48644-9 | Vanillylmandelate and Homovanillate panel - 24 hour Urine |
| 48760-3 | 3-Hydroxy fatty acid panel - Serum or Plasma |
| 48770-2 | Fetal Biophysical profile panel US |
| 48796-7 | Hepatitis C virus FibroSURE panel - Serum or Plasma |
| 48797-5 | Organic acids panel - Urine |
| 48798-3 | First trimester maternal screen panel - Serum or Plasma |
| 48799-1 | Second trimester penta maternal screen panel - Serum or Plasma |
| 48800-7 | Second trimester quad maternal screen panel - Serum or Plasma |
| 48802-3 | Alpha-1-Fetoprotein panel - Serum or Plasma |
| 48805-6 | Platelet aggregation panel - Platelet rich plasma |
| 48808-0 | Leukogram panel - Blood |
| 48809-8 | Erythrogram panel - Blood |
| 48811-4 | Protein fractions 3 panel - Serum or Plasma |
| 48812-2 | Spermatozoa morphology panel |
| 48824-7 | Respiratory allergen panel, US - North Atlantic states a - Serum |
| 48825-4 | Respiratory allergen panel, US - Mid Atlantic states - Serum |
| 48826-2 | Respiratory allergen panel, US - South Atlantic states a - Serum |
| 48827-0 | Respiratory allergen panel, US - Subtropical Florida - Serum |
| 48828-8 | Respiratory allergen panel, US - Greater Ohio valley a - Serum |
| 48829-6 | Respiratory allergen panel, US - South central states - Serum |
| 48830-4 | Respiratory allergen panel, US - Northern midwest states a - Serum |
| 48831-2 | Respiratory allergen panel, US - Central midwest a - Serum |
| 48832-0 | Respiratory allergen panel, US - Great plains states a - Serum |
| 48833-8 | Respiratory allergen panel, US - Southwestern grassland states - Serum |
| 48834-6 | Respiratory allergen panel, US - Rocky mountain states a - Serum |
| 48835-3 | Respiratory allergen panel, US - Arid southwest - Serum |
| 48836-1 | Respiratory allergen panel, US - Southern coastal California - Serum |
| 48837-9 | Respiratory allergen panel, US - California central valley - Serum |
| 48838-7 | Respiratory allergen panel, US - Intermountain west a - Serum |
| 48839-5 | Respiratory allergen panel, US - Inland northwest a - Serum |
| 48840-3 | Respiratory allergen panel, US - Cascade Pacific northwest a - Serum |
| 48841-1 | Respiratory allergen panel, US - Alaska a - Serum |
| 48916-1 | Respiratory allergen panel, US - North Atlantic states b - Serum |
| 48917-9 | Respiratory allergen panel, US - South Atlantic states b - Serum |
| 48918-7 | Respiratory allergen panel, US - NC, PA, SC, VA, WV - Serum |
| 48919-5 | Respiratory allergen panel, US - Central Florida - Serum |
| 48920-3 | Respiratory allergen panel, US - Southern Florida - Serum |
| 48921-1 | Respiratory allergen panel, US - Southeast coast - Serum |
| 48922-9 | Respiratory allergen panel, US - West south central states - Serum |
| 48923-7 | Respiratory allergen panel, US - Greater Ohio valley b - Serum |
| 48924-5 | Respiratory allergen panel, US - Northern midwest states b - Serum |
| 48925-2 | Respiratory allergen panel, US - Central midwest b - Serum |
| 48926-0 | Respiratory allergen panel, US - Great plains states b - Serum |
| 48927-8 | Respiratory allergen panel, US - Rocky mountain states b - Serum |
| 48928-6 | Respiratory allergen panel, US - Inland northwest b - Serum |
| 48929-4 | Respiratory allergen panel, US - Cascade Pacific northwest b - Serum |
| 48930-2 | Respiratory allergen panel, US - Intermountain west b - Serum |
| 48931-0 | Respiratory allergen panel, US - AZ, Southeastern CA, Western NM - Serum |
| 48932-8 | Respiratory allergen panel, US - Alaska b - Serum |
| 48933-6 | Respiratory allergen panel, US - Hawaii - Serum |
| 49017-7 | Respiratory allergen panel, US - North Atlantic states c - Serum |
| 49018-5 | Respiratory allergen panel, US - Intermountain west c - Serum |
| 49019-3 | Respiratory allergen panel, US - Puerto Rico - Serum |
| 49020-1 | Respiratory allergen panel, US - Coastal California - Serum |
| 49021-9 | Respiratory allergen panel, US - Greater Ohio valley c - Serum |
| 49022-7 | Respiratory allergen panel, US - Northern midwest states c - Serum |
| 49037-5 | Respiratory syncytial virus IgG and IgM panel [Units/volume] - Serum |
| 49044-1 | Diazepam and Nordiazepam panel [Mass/volume] - Serum or Plasma |
| 49045-8 | PT and aPTT and Fibrinogen panel - Platelet poor plasma by Coagulation assay |
| 49085-4 | First and Second trimester integrated maternal screen panel |
| 49086-2 | First trimester maternal screen with nuchal translucency panel |
| 49087-0 | Maternal screen clinical predictors panel |
| 49093-8 | Arbovirus IgG and IgM panel - Serum by Immunofluorescence |
| 49094-6 | Arbovirus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 49120-9 | Immunodeficiency follow-up panel - Unspecified specimen by Flow cytometry (FC) |
| 49143-1 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel |
| 49222-3 | Food allergen panel - Serum |
| 49589-5 | Bacterial susceptibility panel by Gradient strip (E-test) |
| 49660-4 | HIV genotype panel |
| 49665-3 | HIV phenotype panel |
| 49883-2 | Hepatitis B virus resistance panel by Genotype method |
| 49885-7 | Lymphocyte proliferation.beryllium stimulation panel - Blood |
| 50009-0 | Fetal lung maturity panel - Amniotic fluid |
| 50023-1 | Hepatitis C virus RNA panel (viral load) in Serum or Plasma by Probe and target amplification method |
| 50025-6 | Volatiles panel - Serum or Plasma |
| 50179-1 | Calcitonin Calcium and Pentagastrin challenge panel - Serum or Plasma |
| 50189-0 | Neonatal bilirubin panel [Mass/volume] - Serum or Plasma |
| 50190-8 | Iron and Iron binding capacity panel - Serum or Plasma |
| 50191-6 | Occult blood panel - Gastric fluid |
| 50196-5 | Occult blood panel - Stool |
| 50197-3 | aPTT panel - Platelet poor plasma |
| 50219-5 | Respiratory virus DNA and RNA panel - Unspecified specimen by Probe and target amplification method |
| 50261-7 | Deprecated Renal function panel & Glomerular filtration rate.predicted |
| 50262-5 | Reticulocytes panel - Blood |
| 50334-2 | Acylglycines panel [Mass Ratio] - Urine |
| 50337-5 | Carbamazepine free and total and 10,11-Epoxide panel [Mass/volume] - Serum or Plasma |
| 50399-5 | Deprecated Clinical genetic report summary panel in Blood or Tissue by Molecular genetics method |
| 50545-3 | Bacterial susceptibility panel by Minimum inhibitory concentration (MIC) |
| 50546-1 | Bacterial susceptibility panel by Disk diffusion (KB) |
| 50554-5 | Urinalysis microscopic panel [#/volume] - Urine by Automated count |
| 50556-0 | Urinalysis dipstick panel - Urine by Automated test strip |
| 50564-4 | Urinalysis panel - Urine by Auto |
| 50579-2 | Gastric analysis panel - Gastric fluid |
| 50580-0 | Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel - Serum or Plasma |
| 50581-8 | Adenosine monophosphate.cyclic stimulation panel - Urine |
| 50582-6 | Glucose tolerance gestational panel - Urine and Serum or Plasma |
| 50583-4 | Glucose screen gestational panel - Urine and Serum or Plasma |
| 50584-2 | Lactose challenge (hydrogen breath test) panel - Exhaled gas |
| 50585-9 | Triple bolus stimulation panel - Serum or Plasma |
| 50586-7 | Glucose tolerance 3 hours panel - Serum or Plasma |
| 50587-5 | Glucose tolerance 4 hours panel - Serum or Plasma |
| 50588-3 | Glucose tolerance 5 hours panel - Serum or Plasma |
| 50589-1 | Glucose tolerance 6 hours panel - Serum or Plasma |
| 50604-8 | HPA panel [Type] in Blood |
| 50607-1 | Neisseria meningitidis Ag panel - Unspecified specimen by Latex agglutination |
| 50608-9 | Glucose tolerance 3 hours gestational panel - Serum or Plasma |
| 50624-6 | HIV 1 RNA panel (viral load) in Cerebral spinal fluid by Probe and target amplification method |
| 50673-3 | Insulin XXX challenge panel - Serum |
| 50676-6 | Calcium-phosphorus product panel [Mass/volume] - Serum or Plasma |
| 50677-4 | Semen analysis post vasectomy panel |
| 50710-3 | Influenza virus susceptibility panel |
| 50736-8 | Serotonin release.heparin.unfractionated panel - Serum |
| 50737-6 | Serotonin release.heparin.porcine panel - Serum |
| 50738-4 | Serotonin release.heparin.low molecular weight panel - Serum |
| 50739-2 | Serotonin release.heparin.porcine and low molecular weight panel - Serum |
| 50943-0 | Reasons for assessment (full) Set |
| 51410-9 | Environmental stressors panel - Water |
| 51411-7 | Environmental stressors panel - Air |
| 51662-5 | Core respiratory allergens panel - Serum |
| 51782-1 | Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method |
| 51956-1 | DNA region analysis test coverage panel - Blood or Tissue by Molecular genetics method |
| 51960-3 | DNA marker results panel - Blood or Tissue by Molecular genetics method |
| 51962-9 | Pharmacogenetic DNA analysis panel - Blood or Tissue by Molecular genetics method |
| 51966-0 | Genetic disease DNA analysis panel - Blood or Tissue by Molecular genetics method |
| 51972-8 | Gas panel - Venous cord blood |
| 51973-6 | Gas panel - Mixed venous blood |
| 51974-4 | Gas panel - Arterial cord blood |
| 51990-0 | Basic metabolic panel - Blood |
| 51991-8 | Reference lab test panel |
| 51992-6 | Heavy metals panel - Serum or Plasma |
| 51993-4 | Metanephrine and Normetanephrine panel [Mass/volume] - Urine |
| 52135-1 | t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel - Blood or Tissue by Molecular genetics method |
| 52762-2 | Intrinsic coagulation system thromboelastography panel - Blood |
| 52763-0 | Extrinsic coagulation system thromboelastography panel - Blood |
| 52764-8 | Extrinsic coagulation system with fibrinolysis inhibition thromboelastography panel - Blood |
| 52765-5 | Thromboelastography without activation panel - Blood |
| 52777-0 | Intrinsic coagulation system with heparin inhibition thromboelastography panel - Blood |
| 53041-0 | DNA region of interest panel - Blood or Tissue by Molecular genetics method |
| 53042-8 | DNA marker assessed panel - Blood or Tissue by Molecular genetics method |
| 53043-6 | DNA marker analysis test coverage panel - Blood or Tissue by Molecular genetics method |
| 53044-4 | DNA marker identified panel - Blood or Tissue by Molecular genetics method |
| 53261-4 | Amino acid newborn screen panel |
| 53262-2 | Carnitine newborn screen panel |
| 53263-0 | Urinalysis yeast variants panel - Urine by Computer assisted method |
| 53264-8 | Urinalysis yeast variants panel [#/volume] - Urine by Computer assisted method |
| 53267-1 | Urinalysis yeast variants panel [#/area] - Urine by Computer assisted method |
| 53270-5 | Urinalysis type of non-squamous epithelial cells panel - Urine by Computer assisted method |
| 53273-9 | Urinalysis type of non-squamous epithelial cells panel [#/volume] - Urine by Computer assisted method |
| 53276-2 | Urinalysis type of non-squamous epithelial cells panel [#/area] - Urine by Computer assisted method |
| 53277-0 | Urinalysis type of cast panel - Urine by Computer assisted method |
| 53281-2 | Urinalysis type of cast panel [#/volume] - Urine by Computer assisted method |
| 53293-7 | Urinalysis microscopic panel [#/area] - Urine sediment by Automated count |
| 53295-2 | Urinalysis type of crystal panel [#/volume] - Urine by Computer assisted method |
| 53305-9 | Urinalysis type of crystal panel [#/area] - Urine by Computer assisted method |
| 53325-7 | Urinalysis type of crystal panel - Urine by Computer assisted method |
| 53330-7 | Urinalysis type of cast panel [#/area] - Urine by Computer assisted method |
| 53333-1 | Urinalysis other formed elements panel - Urine by Computer assisted method |
| 53351-3 | Urinalysis other formed elements panel [#/volume] - Urine by Computer assisted method |
| 53575-7 | VAP cholesterol panel - Serum or Plasma |
| 53598-9 | Irritable bowel disease prognostic panel - Serum or Plasma by Immunoassay |
| 53703-5 | Mycobacterium bovis tuberculin stimulated gamma interferon panel - Blood |
| 53705-0 | Myasthenia gravis evaluation pediatric panel - Serum |
| 53706-8 | Myasthenia grav eval adult rflx panel - Serum |
| 53745-6 | Benzodiazepines panel - Urine |
| 53746-4 | Barbiturates panel - Urine |
| 53747-2 | Cocaine panel - Urine |
| 53759-7 | Natural killer cell panel - Blood by Flow cytometry (FC) |
| 53764-7 | Prostate specific Ag panel - Serum or Plasma |
| 53766-2 | Estrogen fraction panel - Serum or Plasma |
| 53775-3 | Hepatitis A virus Ab panel - Serum |
| 53780-3 | Chromium panel - Urine |
| 53781-1 | Acetaminophen and Propoxyphene panel [Mass/volume] - Urine |
| 53783-7 | HTT gene mutation panel - Blood or Tissue by Molecular genetics method |
| 53800-9 | Platelets panel - Blood by Automated count |
| 53803-3 | Transferrin.carbohydrate deficient panel - Serum or Plasma |
| 53804-1 | Arbovirus IgG panel - Serum by Immunofluorescence |
| 53932-0 | Streptococcus pneumoniae 14a and Corynebacterium diphtheriae toxin and Clostridium tetani toxin Ab.IgG panel - Serum |
| 54075-7 | Endocrine newborn screening panel (SI units) |
| 54076-5 | Endocrine newborn screening panel |
| 54077-3 | Thyroid newborn screening panel (SI units) |
| 54078-1 | Cystic fibrosis newborn screening panel |
| 54079-9 | Galactosemia newborn screening panel |
| 54080-7 | Galactosemia newborn screening panel (SI units) |
| 54081-5 | Hemoglobinopathies newborn screening panel |
| 54082-3 | Infectious diseases newborn screening panel |
| 54089-8 | Newborn screening panel American Health Information Community (AHIC) |
| 54090-6 | Thyroid newborn screening panel |
| 54097-1 | Organophosphonate nerve agent metabolite panel [Mass/volume] - Urine |
| 54111-0 | Newborn hearing screening panel |
| 54145-8 | Bacterial vaginosis and vaginitis DNA panel - Vaginal fluid by Probe and signal amplification method |
| 54225-8 | Immune response panel - Unspecified specimen by Flow cytometry (FC) |
| 54226-6 | Lymphoma panel - Unspecified specimen by Flow cytometry (FC) |
| 54227-4 | Lymphoma - acute screen panel - Unspecified specimen by Flow cytometry (FC) |
| 54228-2 | Lymphoma - CLL screen panel - Unspecified specimen by Flow cytometry (FC) |
| 54229-0 | Lymphoma - T-cell screen panel - Unspecified specimen by Flow cytometry (FC) |
| 54230-8 | Cell count and Diff panel with Gluc and Prot - Cerebral spinal fluid |
| 54231-6 | Semen analysis fertility panel |
| 54232-4 | Metabolic panel.large animal - Serum or Plasma |
| 54233-2 | Metabolic panel.small animal - Serum or Plasma |
| 54234-0 | Cell count and Diff panel with Gluc and Prot - Body fluid |
| 54235-7 | Cortisol challenge panel - Saliva (oral fluid) |
| 54246-4 | Protein and Glucose panel [Mass/volume] - Body fluid |
| 54450-2 | CYP2C9 and VKORC1 panel - Blood or Tissue by Molecular genetics method |
| 54932-9 | Centers for Environmental Health abrine and ricinine panel [Mass/volume] - Urine |
| 55101-0 | Respiratory virus panel - Unspecified specimen by Organism specific culture |
| 55116-8 | Centers for Environmental Health volatile organic compounds panel [Mass/volume] - Serum or Plasma |
| 55117-6 | Centers for Environmental Health trace metals screen panel [Mass/volume] - Urine |
| 55118-4 | Centers for Environmental Health trace metals panel [Mass/volume] - Urine |
| 55119-2 | Centers for Environmental Health nitrogen mustard metabolite panel [Mass/volume] - Urine |
| 55120-0 | Centers for Environmental Health metabolic toxin panel [Mass/volume] - Urine |
| 55121-8 | Multiple sclerosis panel - Serum and CSF |
| 55150-7 | Anaplasma phagocytophilum IgG and IgM panel - Serum Qualitative |
| 55151-5 | Aldosterone and Renin panel - Plasma |
| 55152-3 | Amiodarone and Desethylamiodarone panel [Mass/volume] - Serum or Plasma |
| 55153-1 | Biotinidase panel - Serum or Plasma |
| 55155-6 | Flunitrazepam and 7-Aminoflunitrazepam panel [Mass/volume] - Urine |
| 55157-2 | Risperidone and 9-Hydroxyrisperidone panel - Serum or Plasma |
| 55160-6 | Adenovirus IgG and IgM panel - Serum |
| 55161-4 | Bordetella pertussis IgA and IgG panel - Serum by Immunoassay |
| 55162-2 | HTLV 1+2 Ab panel - Serum Qualitative |
| 55163-0 | Streptococcus pyogenes enzyme Ab panel - Serum Qualitative |
| 55164-8 | Paroxysmal nocturnal panel - Blood |
| 55207-5 | Genetic analysis discrete result panel - Blood or Tissue by Molecular genetics method |
| 55208-3 | DNA analysis discrete sequence variation panel - Blood or Tissue by Molecular genetics method |
| 55231-5 | Electrolytes panel - Blood |
| 55232-3 | Genetic analysis summary panel - Blood or Tissue by Molecular genetics method |
| 55233-1 | Genetic analysis master panel - Blood or Tissue by Molecular genetics method |
| 55234-9 | Alpha thalassemia gene deletion panel [Presence] - Blood by Molecular genetics method |
| 55235-6 | Abnormal hemoglobin gene panel - Blood by Molecular genetics method |
| 55255-4 | Pyridinoline panel - Urine |
| 55295-0 | Protein electrophoresis and Immunoglobulins panel - Serum |
| 55394-1 | Protein and Glucose panel - Cerebral spinal fluid |
| 55395-8 | Phospholipid IgA and IgG and IgM panel - Serum |
| 55396-6 | Beta 2 glycoprotein 1 IgA and IgG panel - Serum |
| 55397-4 | Short myasthenia gravis panel - Serum |
| 55398-2 | Short Fibrin D-dimer FEU and DDU panel - Platelet poor plasma |
| 55399-0 | Diabetes tracking panel |
| 55401-4 | Warfarin tracking panel - Platelet poor plasma |
| 55402-2 | West Nile virus IgG and IgM panel - Serum |
| 55403-0 | Asthma tracking panel |
| 55405-5 | Heart failure tracking panel |
| 55409-7 | Exercise tracking panel |
| 55413-9 | Pedometer tracking panel |
| 55415-4 | Oxygen therapy tracking panel |
| 55417-0 | Short blood pressure panel |
| 55418-8 | Weight and Height tracking panel |
| 55419-6 | Home drug screening panel - Urine |
| 55427-9 | Seizure disorder tracking panel |
| 55429-5 | Short blood count panel - Blood |
| 55441-0 | Antithrombin Ag in Platelet poor plasma |
| 55442-8 | Antithrombin in Platelet poor plasma |
| 55443-6 | Cardiolipin Ab in Serum |
| 55444-4 | Cardiolipin IgA Ab in Serum |
| 55445-1 | Cardiolipin IgM Ab in Serum |
| 55446-9 | Cardiolipin IgG Ab in Serum |
| 55447-7 | Coagulation factor VIII Ag in Platelet poor plasma |
| 55448-5 | Complement total hemolytic CH50 in Serum or Plasma |
| 55449-3 | Fibrin D-dimer in Platelet poor plasma |
| 55450-1 | Fibrin+Fibrinogen fragments in Serum |
| 55451-9 | Fibrin+Fibrinogen fragments in Platelet poor plasma |
| 55452-7 | Fibrinogen in Platelet poor plasma |
| 55453-5 | Haptoglobin in Serum or Plasma |
| 55454-3 | Hemoglobin A1c in Blood |
| 55455-0 | Hemoglobin F in Unspecified specimen |
| 55456-8 | Hemoglobin S in Blood |
| 55457-6 | Free Hemoglobin in Plasma |
| 55458-4 | Interferon alpha in Serum or Plasma |
| 55459-2 | Prekallikrein (Fletcher Factor) in Platelet poor plasma |
| 55460-0 | Protein C Ag in Platelet poor plasma |
| 55461-8 | Protein C in Platelet poor plasma |
| 55462-6 | Thyrotropin in Serum or Plasma |
| 55466-7 | Influenza virus A H1 2009 pandemic RNA panel - Unspecified specimen by Probe and target amplification method |
| 55728-0 | Yersinia sp IgG and IgM panel - Serum |
| 55744-7 | howRU |
| 56146-4 | Fungal Ab panel - Serum |
| 56148-0 | Smith extractable nuclear Ab and Ribonucleoprotein extractable nuclear Ab panel - Serum |
| 56149-8 | Beta 2 glycoprotein and Cardiolipin Ab and Phosphatidylserine panel - Serum |
| 56152-2 | Beta 2 glycoprotein 1 Ab IgA and IgG and IgM panel - Serum |
| 56156-3 | Candida albicans IgA and IgG and IgM Ab panel - Serum |
| 57019-2 | Urinalysis dipstick W Reflex Culture panel - Urine |
| 57020-0 | Urinalysis dipstick W Reflex Microscopic panel - Urine |
| 57021-8 | CBC W Auto Differential panel - Blood |
| 57022-6 | CBC W Reflex Manual Differential panel - Blood |
| 57023-4 | Auto Differential panel - Blood |
| 57031-7 | Herpesviruses 6 DNA panel - Unspecified specimen by Probe and target amplification method |
| 57084-6 | Fatty acid oxidation newborn screen panel |
| 57085-3 | Organic acid newborn screen panel |
| 57086-1 | Congenital adrenal hyperplasia newborn screening panel |
| 57087-9 | Biotinidase newborn screening panel |
| 57128-1 | Newborn Screening Report summary panel |
| 57698-3 | Lipid panel with direct LDL - Serum or Plasma |
| 57717-1 | Newborn screen card data panel |
| 57765-0 | Disaccharidases panel - Small intestine Tissue |
| 57767-6 | Trimipramine and Nortrimipramine panel - Serum or Plasma |
| 57770-0 | Toxoplasma gondii IgG and IgM panel - Serum |
| 57772-6 | Metanephrine.free and Normetanephrine.free panel [Moles/volume] - Serum or Plasma |
| 57774-2 | Colorado tick fever virus IgG and IgM panel [Titer] - Serum |
| 57775-9 | Valproate.free and Valproate panel - Serum or Plasma |
| 57776-7 | Gliadin peptide IgA and IgG panel - Serum |
| 57777-5 | Myeloperoxidase Ab and Proteinase 3 panel - Serum |
| 57778-3 | Immunoglobulin light chains.free panel - Serum |
| 57780-9 | Thyroglobulin and Thyrogobulin Ab panel - Serum or Plasma |
| 57782-5 | CBC with Ordered Manual Differential panel - Blood |
| 57794-0 | Newborn screening test results panel - Dried blood spot |
| 57795-7 | Fecal hydrolysis panel - Stool |
| 57803-9 | Occult blood panel - Stool by Immunologic method |
| 58077-9 | Urinalysis complete W Reflex Culture panel - Urine |
| 58091-0 | Glucose-6-Phosphate dehydrogenase newborn screen panel |
| 58092-8 | Acylcarnitine newborn screen panel |
| 58406-0 | Platelet morphology panel - Blood |
| 58407-8 | Leukocyte morphology panel - Blood |
| 58408-6 | Erythrocyte morphology panel - Blood |
| 58410-2 | Complete blood count (hemogram) panel - Blood by Automated count |
| 58431-8 | Microalbumin panel - 24 hour Urine |
| 58446-6 | Creatinine 24H renal clearance adjusted for body surface area panel |
| 58447-4 | Microalbumin/Creatinine panel in 24H Urine |
| 58713-9 | Streptococcal DNAse B and ASO antibodies panel - Serum |
| 58715-4 | Adulterants panel - Urine |
| 58716-2 | Testosterone.bioavailable and total panel - Serum or Plasma |
| 58732-9 | Porphyrin fractions panel - Serum or Plasma |
| 58733-7 | Mycoplasma pneumoniae IgG and IgM panel - Serum |
| 58735-2 | Alpha-1-Fetoprotein panel - Amniotic fluid |
| 58736-0 | Manganese panel - Urine |
| 58953-1 | Meperidine and Normeperidine panel - Urine |
| 59049-7 | Coccidioides sp IgG and IgM panel - Unspecified specimen |
| 59059-6 | Inflammatory bowel disease Ab 7 panel - Serum |
| 59062-0 | Lipoprofile panel - Serum or Plasma |
| 59063-8 | Lymphocyte proliferation panel - Blood |
| 59257-6 | Cell count and Differential panel - Pericardial fluid |
| 59852-4 | North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel |
| 60342-3 | Borrelia burgdorferi IgG panel - Serum by Immunoblot (IB) |
| 60343-1 | Borrelia burgdorferi IgM panel - Serum by Immunoblot (IB) |
| 60566-7 | Respiratory virus DNA and RNA 12 panel - Unspecified specimen by Probe and target amplification method |
| 60587-3 | Cell count and Differential panel - Peritoneal dialysis fluid |
| 62300-9 | Lysosomal storage disorders newborn screening panel |
| 62304-1 | Fabry disease newborn screening panel |
| 62307-4 | Krabbe disease newborn screening panel |
| 62311-6 | Gaucher disease newborn screening panel |
| 62315-7 | Niemann Pick disease A/B newborn screening panel |
| 62333-0 | Severe combined immunodeficiency (SCID) newborn screening panel |
| 62341-3 | Borrelia burgdorferi IgG+IgM with reflex to immune blot panel - Serum |
| 62426-2 | Bordetella sp DNA panel - Unspecified specimen by Probe and target amplification method |
| 63414-7 | Pompe disease newborn screening panel |
| 63430-3 | Human coronavirus RNA panel - Unspecified specimen by Probe and target amplification method |
| 63486-5 | Nut allergen panel - Serum |
| 64017-7 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Unspecified specimen by Probe and target amplification method |
| 64116-7 | Hemoglobin observations newborn screening panel |
| 64418-7 | KIR genotyping panel - Blood or Tissue |
| 64433-6 | Fragile X protein (FMRP) panel - Blood |
| 65632-2 | Clozapine and Norclozapine panel - Serum or Plasma |
| 65634-8 | Creatinine 24 hour urine panel - 24 hour Urine |
| 65750-2 | Drugs of abuse 5 panel - Urine by Screen method |
| 65758-5 | CD4 T-cell absolute panel - Blood |
| 65759-3 | T-cell subsets CD4 and CD8 panel - Blood |
| 65833-6 | Address Facility |
| 67767-4 | HEDIS 2012 panel |
| 67790-6 | Thromboelastography panel - Blood |
| 67795-5 | Vital signs, weight, height, head circumference and oximetry panel HITSP |
| 67822-7 | Fentanyl and Norfentanyl panel - Urine |
| 67866-4 | Babesia identification panel - Unspecified specimen |
| 68314-4 | Meperidine and Normeperidine panel - Serum or Plasma |
| 68315-1 | Transcortin and Cortisol.free panel - Serum or Plasma |
| 68317-7 | Metanephrine, Normetanephrine and Creatinine panel - Urine |
| 68318-5 | Hypoglycemics panel - Serum or Plasma |
| 68320-1 | Polio virus Ab panel [Titer] - Serum |
| 68501-6 | Serotonin release.heparin.unfractionated and low molecular weight panel - Serum |
| 68982-8 | PFGE panel - Isolate |
| 68991-9 | Epidemiologically important information for public health reporting panel |
| 68992-7 | Specimen-related information panel |
| 69008-1 | Cocaine panel - Meconium by Confirmatory method |
| 69018-0 | Lymphocyte proliferation mitogen panel - Blood by Flow cytometry (FC) |
| 69021-4 | Amphetamines panel - Meconium by Confirmatory method |
| 69026-3 | Opiates panel - Meconium by Confirmatory method |
| 69034-7 | Eastern equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
| 69035-4 | Eastern equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 69036-2 | Western equine encephalitis virus IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence |
| 69039-6 | Enterocyte Ab panel - Serum |
| 69040-4 | Chronic urticaria index panel - Serum or Plasma |
| 69041-2 | Western equine encephalitis virus IgG and IgM panel - Serum by Immunofluorescence |
| 69042-0 | Lymphocyte proliferation antigen panel - Blood by Flow cytometry (FC) |
| 69459-6 | Care record summary panel |
| 69552-8 | Thromboelastography after addtion of heparinase panel - Blood |
| 69554-4 | Lactose tolerance panel [Moles/volume] in Serum or Plasma |
| 69555-1 | Lactose tolerance panel [Mass/volume] in Serum or Plasma |
| 69571-8 | Bacterial vaginosis DNA and score panel - Vaginal fluid by Probe and target amplification method |
| 69581-7 | National (USA) PFGE cluster code or CDC cluster [Identifier] in Isolate |
| 69726-8 | Tissue transglutaminase IgA + Gliadin peptides Ab.IgA and IgG panel - Serum |
| 69738-3 | Differential panel, method unspecified - Blood |
| 69739-1 | Drugs of abuse panel - Urine |
| 69740-9 | Cell count panel - Pericardial fluid |
| 69741-7 | Differential panel - Pericardial fluid |
| 69742-5 | CBC W Differential panel, method unspecified - Blood |
| 69999-1 | Positive airway pressure panel |
| 70130-0 | Rickettsia typhus group and Rickettsia spotted fever group acute and convalescent IgG and IgM panel - Serum by Immunofluorescence |
| 70161-5 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urine by Probe and target amplification method |
| 70162-3 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Urethra by Probe and target amplification method |
| 70163-1 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Cervix by Probe and target amplification method |
| 70164-9 | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Vaginal fluid by Probe and target amplification method |
| 70219-1 | Basic metabolic 2008 panel with ionized calcium - Serum or Plasma |
| 71432-9 | Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA - Cervix |
| 71775-1 | Mycobacterium tuberculosis stimulated gamma interferon panel - Blood |
| 72103-5 | Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method |
| 72104-3 | Acute and chronic leukemia fusion transcript per control transcript panel - Blood or Tissue by Molecular genetics method |
| 72105-0 | Vital signs and oximetry - admission, home health, interim, discharge [CARE] |
| 72171-2 | Glucose tolerance 2 hours panel - Serum or Plasma |
| 72199-3 | HEDIS 2013 panel |
| 72203-3 | Parathyrin.intact intraoperative panel - Serum or Plasma |
| 72257-9 | Platelet function.collagen + Adenosine diphosphate induced and Epinephrine induced panel - Blood |
| 72264-5 | Bilirubin excess and oxyhemoglobin and methemoglobin and xanthochromia and albumin quotient panel - Serum and CSF |
| 72272-8 | Amylase and triacylglycerol lipase panel - Serum or Plasma |
| 72283-5 | Nail assessment panel |
| 72284-3 | Skin assessment panel |
| 72286-8 | Wound dressing panel |
| 72287-6 | Wound size panel |
| 72292-6 | Wound exudate panel |
| 72299-1 | Wound tunneling and undermining panel |
| 72369-2 | Body site identification panel |
| 72372-6 | Wound bed and edge panel |
| 72393-2 | Cell count and Differential panel - Vitreous fluid by Manual count |
| 72394-0 | Cell count panel - Vitreous fluid by Manual count |
| 72395-7 | Differential panel - Vitreous fluid |
| 72476-5 | Methadone panel - Saliva (oral fluid) by Confirmatory method |
| 72478-1 | Synthetic cannabinoids panel - Urine by Confirmatory method |
| 72479-9 | Drugs of abuse panel - Blood by Screen method |
| 72480-7 | Barbiturates panel - Blood by Confirmatory method |
| 72481-5 | Candida sp 6 panel - Vaginal fluid by Probe and target amplification method |
| 72488-0 | Beta 2 glycoprotein 1 IgG and IgM panel - Serum |
| 72661-2 | Intrinsic coagulation factor activity 4 panel - Platelet poor plasma by Coagulation assay |
| 72662-0 | Extrinsic coagulation factor activity 4 panel - Platelet poor plasma |
| 72670-3 | Metanephrine, Normetanephrine, 3-Methoxytyramine and Creatinine panel - Urine |
| 72694-3 | Cholinesterase activity panel - Serum or Plasma |
| 72695-0 | Erythrocyte enzyme panel - Red Blood Cells |
| 72718-0 | Borderline symptom list - behavior supplement |
| 72719-8 | Borderline symptom list - 23 item [BSL-23] |
| 72727-1 | Del(13)(q14) and del(17)(p13) in Blood or Tissue |
| 72828-7 | Chlamydia trachomatis and Neisseria gonorrhoeae DNA panel - Unspecified specimen |
| 72852-7 | Cytomegalovirus resistance panel by Genotype method |
| 72862-6 | Hepatitis C virus resistance panel by Genotype method |
| 72886-5 | CYP2D6 gene and CYP2C19 gene mutation analysis panel - Blood, Tissue or Saliva |
| 72892-3 | Staphylococcus aureus and Methicillin (mecA) genes panel by Probe and target amplification method |
| 72905-3 | Neutrophil Ab and HLA Ab screen panel - Serum or Plasma |
| 72906-1 | HNA Ab panel - Serum or Plasma |
| 72907-9 | HNA genotype panel - Serum or Plasma |
| 72908-7 | Drug induced platelet Ab panel - Serum or Plasma |
| 72909-5 | Drug induced neutrophil Ab panel - Serum or Plasma |
| 73660-3 | Propoxyphene panel - Saliva (oral fluid) |
| 73661-1 | Methadone panel - Saliva (oral fluid) by Screen method |
| 73662-9 | Benzodiazepines panel - Saliva (oral fluid) by Screen method |
| 73663-7 | Barbiturates panel - Saliva (oral fluid) by Confirmatory method |
| 73724-7 | Bile acid dihydroxy and trihydroxy panel - Serum or Plasma |
| 73725-4 | Bile acid panel - 24 hour Stool |
| 73738-7 | Newborn screening test results panel - Point of Care |
| 73741-1 | Newborn hearing screen panel of Ear - left |
| 73744-5 | Newborn hearing screen panel of Ear - right |
| 73790-8 | Neonatal skin risk assessment scale panel [NSRAS] |
| 73805-4 | CCHD newborn screening panel |
| 73852-6 | 7-Dehydrocholesterol and 8-Dehydrocholesterol panel - Serum or Plasma |
| 73865-8 | Catecholamines 3 panel [Moles/volume] - Plasma |
| 73866-6 | Catecholamines 3 and creatinine panel [Molar ratio] - Urine |
| 73879-9 | Catecholamine metabolites and creatinine panel - Urine |
| 73885-6 | Steroid fractions panel - 24 hour Urine |
| 73886-4 | Steroid fractions panel - Urine |
| 73897-1 | Chronic lyme disease panel - Blood by Flow cytometry (FC) |
| 73967-2 | Noninvasive prenatal fetal aneuploidy test panel - Plasma cell-free DNA |
| 73979-7 | Keyhole limpet hemocyanin Ab panel - Serum or Plasma |
| 74028-2 | Virtual Medical Record for Clinical Decision Support panel HL7.VMR-CDS |
| 74029-0 | Periodontal attachment - recommended CDA set |
| 74032-4 | Arbovirus IgM panel - Serum |
| 74080-3 | Patient safety event report - hospital: medication or other substance - version 1.2 [AHRQ] |
| 74182-7 | NMMDS job satisfaction panel |
| 74219-7 | Weight difference pre dialysis and post dialysis panel |
| 74281-7 | Mycobacterium tuberculosis stimulated gamma interferon and spot count panel - Blood |
| 74352-6 | Cryoglobulin and cryofibrinogen panel - Serum and Plasma |
| 74353-4 | Sodium and Potassium panel [Moles/volume] - Blood |
| 74408-6 | Middle east respiratory syndrome coronavirus (MERS-CoV) RNA panel - Unspecified specimen |
| 74409-4 | MICA IgG panel - Serum |
| 74410-2 | Polychlorinated biphenyl (PCB) panel - Serum or Plasma by Confirmatory method |
| 74412-8 | CBC W Differential panel - Cord blood |
| 74413-6 | Differential panel - Cord blood |
| 74439-1 | Gamma aminobutyrate free and total panel - Cerebral spinal fluid |
| 74445-8 | Porphyrin fractions panel [Moles/mass] - Stool |
| 74446-6 | Stone analysis panel |
| 74447-4 | Sugars and polyols panel [Molar ratio] - Urine |
| 74514-1 | Amino acids panel [Moles/volume] - Urine |
| 74519-0 | Complement functional activity panel - Serum |
| 74526-5 | Delta aminolevulinate, porphobilinogen and creatinine panel - 24 hour Urine |
| 74527-3 | Delta aminolevulinate, porphobilinogen and creatinine panel - Urine |
| 74545-5 | Tryptophan-related indole profiling panel - Platelet rich plasma |
| 74633-9 | Dimethylacetal (DMA) panel - Fibroblast |
| 74634-7 | Dimethylacetal (DMA) panel - Red Blood Cells |
| 74635-4 | Bacterial vaginosis DNA panel - Vaginal fluid by Probe and target amplification method |
| 74728-7 | Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.CCDAr1.1 |
| 74749-3 | Gram positive blood culture panel by Nucleic acid capture and probe detection on Positive blood culture |
| 74760-0 | Hydrocodone and hydromorphone panel - Urine by Confirmatory method |
| 74764-2 | Soluble fms-like tyrosine kinase-1 and placental growth factor panel - Serum or Plasma |
| 74773-3 | Immunoglobulin light chains and heavy chains panel - Serum or Plasma |
| 74787-3 | Influenza virus B Victoria and Yamagata lineage RNA panel - Unspecified specimen |
| 74788-1 | Lactulose challenge (hydrogen breath test) panel - Exhaled gas |
| 74789-9 | Fructose challenge (hydrogen breath test) panel - Exhaled gas |
| 74790-7 | Glucose challenge (hydrogen breath test) panel - Exhaled gas |
| 74831-9 | Metanephrine and Normetanephrine panel [Moles/volume] - Urine |
| 74835-0 | Porphyrin fractions panel - Stool |
| 74874-9 | Metabolic disorder therapy monitoring panel - Dried blood spot |
| 74885-5 | HER2 panel - Tissue by Fluorescent in situ hybridization (FISH) |
| 74888-9 | Sterols panel [Moles/volume] - Serum or Plasma |
| 74914-3 | Acylglycines panel [Molar ratio] - Urine |
| 74978-8 | Cerebroside sulfatase and N-Acetylgalactosamine-4-Sulfatase panel [Enzymatic activity/mass] - Leukocytes |
| 74991-1 | Amino acids panel [Molar ratio] - Urine |
| 74993-7 | Chloride and sodium panel [Moles/volume] - Sweat |
| 75021-6 | Olanzapine panel - Serum or Plasma |
| 75199-0 | Congenital syphilis case investigation and report panel [CDC.CS] |
| 75243-6 | Norton scale panel |
| 75256-8 | Disability information and assistance needed panel [HHS.ACA Section 4302.ONC] |
| 75258-4 | PROMIS short form - sleep disturbance - 4a - version 1.0 |
| 75259-2 | PROMIS short form - pain intensity - 3a - version 1.0 |
| 75282-4 | Nutrition assessment panel |
| 75283-2 | Food and nutrition history panel |
| 75284-0 | Food and nutrient intake panel |
| 75285-7 | Comparative nutrition assessment standards panel |
| 75286-5 | Nutrition related anthropometric measurements panel |
| 75287-3 | Food and beverage intake panel |
| 75304-6 | Nutrition status observation panel |
| 75418-4 | PCORI patient-reported outcomes common measures - core and recommended [PROMIS] |
| 75419-2 | PCORI patient-reported outcomes recommended measures [PROMIS] |
| 75420-0 | PCORI patient-reported outcomes core pediatric measures [PROMIS] |
| 75421-8 | PCORI patient-reported outcomes core adult measures [PROMIS] |
| 75515-7 | Lupus anticoagulant aPTT and dRVVT screening panel W Reflex |
| 75533-0 | NMMDS accreditation, certification, and licensure panel |
| 75547-0 | Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA |
| 75619-7 | National healthcare survey panel [NAMCS] |
| 75620-5 | TNM clinical staging before treatment panel Cancer |
| 75621-3 | TNM pathologic staging after surgery panel Cancer |
| 75622-1 | HIV 1 and 2 tests - Meaningful Use Set |
| 75635-3 | Rheumatoid arthritis disease activity panel - Serum or Plasma by VectraDA |
| 75641-1 | Electrolytes 3 panel - Cerebral spinal fluid |
| 75667-6 | Electrolytes 3 panel - 24 hour Urine |
| 75673-4 | Gram negative blood culture panel by Nucleic acid capture and probe detection on Positive blood culture |
| 75689-0 | Iron panel - Serum or Plasma |
| 75697-3 | Bilirubin fractions panel [Moles/volume] - Serum or Plasma |
| 75742-7 | Dartmouth COOP Functional Assessment Charts - 2 weeks |
| 75743-5 | Dartmouth COOP Functional Assessment Charts - 4 weeks |
| 75772-4 | Advance directives panel [ADVault] |
| 75814-4 | Antihistamines panel - Serum or Plasma or Urine by Screen method |
| 75815-1 | Antipsychotics drug panel - Blood or Urine by Screen method |
| 75842-5 | Clinical disease activity index [CDAI] |
| 75843-3 | Simplified disease activity index [SDAI] |
| 75858-1 | Sterols panel [Mass/volume] - Serum or Plasma |
| 75860-7 | Hepatitis A virus RNA and Parvovirus B19 DNA panel - Plasma from donor by Probe and target amplification method |
| 75881-3 | Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex |
| 76067-8 | Abbreviated Injury Scale panel AAAM |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
| 1015-7 | Ew Ag [Presence] on Red Blood Cells |
| 1021-5 | E Ag [Presence] on Red Blood Cells |
| 10226-9 | Oxygen content in Intravascular space |
| 10244-2 | Oxygen content in Pulmonary artery - left |
| 10245-9 | Oxygen content in Main pulmonary artery |
| 10246-7 | Oxygen content in Pulmonary artery - right |
| 10247-5 | Oxygen content in Pulmonary wedge |
| 1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells |
| 1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells |
| 10331-7 | Rh [Type] in Blood |
| 10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
| 10336-6 | Gonadotropin peptide [Mass/volume] in Urine |
| 10337-4 | Procollagen peptide.type 1 [Mass/volume] in Serum |
|
Propose a change